首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Multiple sclerosis journal-experimental translational and clinical

缩写:

ISSN:N/A

e-ISSN:2055-2173

IF/分区:2.0/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引609
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Brian M Sandroff,Glenn R Wylie,Brad P Sutton et al. Brian M Sandroff et al.
Exercise training has been identified as a highly promising approach for managing the cognitive consequences of multiple sclerosis (MS). This study represents a secondary analysis of resting-state functional connectivity (RSFC) magnetic res...
Ryohei Ohtani,Masahiro Mori,Tomohiko Uchida et al. Ryohei Ohtani et al.
Background: Lymphopenia is a well-known adverse event of fingolimod, a disease-modifying drug for multiple sclerosis (MS). Objectives: ...
M Mäurer,K Schuh,S Seibert et al. M Mäurer et al.
Background: Fatigue is a major symptom of multiple sclerosis (MS) in patients, and it has been shown to improve with physical exercise. Although fingolimod might lessen fatigue, it is unclear how patients treated with fin...
Victoria Mj Smith,Jonathan S Varsanik,Rachel A Walker et al. Victoria Mj Smith et al.
Background: Gait disturbance is a major contributor to clinical disability in multiple sclerosis (MS). A sensor was developed to assess walking speed at home for people with MS using infrared technology in real-time witho...
J E Sasaki,R W Motl,G Cutter et al. J E Sasaki et al.
Background: Limited data exist on the prevalence and distribution of sedentary behavior (SB) in multiple sclerosis (MS). Objective: The...
Carlos Navas,Carlos A Torres-Duque,Joe Munoz-Ceron et al. Carlos Navas et al.
Background: Multiple sclerosis is an inflammatory and neurodegenerative demyelinating disease. Current treatment of multiple sclerosis focuses on the use of immunomodulatory, immunosuppressant, and selective immunosuppres...
Andrew Eisen,Benjamin M Greenberg,James D Bowen et al. Andrew Eisen et al.
Objective: The objective of this paper is to assess, in individuals with clinically stable multiple sclerosis (MS), the safety, tolerability, pharmacokinetics (PK) and exploratory pharmacodynamics of the monoclonal recomb...
Masaaki Niino,Toshiyuki Fukazawa,Jun-Ichi Kira et al. Masaaki Niino et al.
Background: The Brief International Cognitive Assessment for MS (BICAMS) is a practical battery for measuring cognitive function in multiple sclerosis (MS). ...